@Gérard
le CDC n’est pas sans lien d’intérêts concernant ce vaccin Gardasil
HPV vaccine safety : Cochrane launches urgent investigation into review after criticisms Published 09 August 2018
Cochrane HPV vaccine review severely compromised by conflicts of interest 17 September 2018, Elizabeth M Hart
The recently published Cochrane HPV vaccine review[1] is severely
compromised and cannot be trusted due to the conflicts of interest of
authors on the original protocol and the final review document.
Due to serious conflicts of interests, Cochrane should withdraw this review [The BMJ].
In February 2016, I challenged David Tovey, Editor in Chief of
Cochrane, directly about protocol author Lauri Markowitz’s conflicts of
interest.
Catherine Riva et al raised the problem of conflicts
of interest in December 2014 in a comment on the original protocol[2],
specifically pointing out the failure to properly disclose conflicts of
interest by Lauri Markowitz and Marc Arbyn. Arbyn remained an author
throughout all stages.
Lauri Markowitz is an employee of the US Centers for Disease Control
and Prevention (CDC), and is involved in HPV vaccination promotion. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711299/
The US Government benefits from the sale of HPV vaccine products,
i.e. a letter to Dr Eric Suba from the US National Archives and Records
Administration (November 2010) discusses royalties the US National
Institutes of Health (NIH) receives from the sales of HPV vaccines. (See
a copy of the letter via this link : http://www.vietnamcervicalcancer.org/dmdocuments/ogis%20suba%2024%20nove...)
[...]
The Bill and Melinda Gates Foundation has been very influential in promoting HPV vaccination[5].
In regards to the Cochrane HPV vaccine review, Cochrane has a conflict
of interest in that it is a beneficiary of Bill and Melinda Gates
Foundation funding, i.e. to « support the development of Cochrane’s next
generation evidence system, with a specific focus on maternal and child
health ».[6] The World Mercury Project has provided critical analysis
of Cochrane’s conflicts of interest via the Bill and Melinda Gates
Foundation and other organisations[7].
[...]